Evaluation of adherence to medication treatment in pediatric patients with cystic fibrosis; a cross-sectional study

s. amini (Tehran, Islamic Republic of Iran), S. Jafarrangraz (Tehran, Islamic Republic of Iran), M. Modaresi (Tehran, Islamic Republic of Iran), K. Gholami (Tehran, Islamic Republic of Iran)

Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Session: Treatments, adherence and psychosocial aspects of cystic fibrosis
Session type: Thematic Poster
Number: 4520
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
s. amini (Tehran, Islamic Republic of Iran), S. Jafarrangraz (Tehran, Islamic Republic of Iran), M. Modaresi (Tehran, Islamic Republic of Iran), K. Gholami (Tehran, Islamic Republic of Iran). Evaluation of adherence to medication treatment in pediatric patients with cystic fibrosis; a cross-sectional study. 4520

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Feasibility study of an intervention to increase treatment adherence in children with cystic fibrosis (CF)
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019


Oral L-arginine therapy in patients with cystic fibrosis: a pilot study
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002

Exploring barriers to Pirfenidone adherence in patients with idiopathic pulmonary fibrosis: a prospective study
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


Anti-inflammatory asthma therapy adherence in paediatric patients: The PACMAN cohort study
Source: Annual Congress 2010 - Management of airway disease
Year: 2010


Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



The experience of patients with cystic fibrosis during pulmonary exacerbations: a mixed-method study
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Year: 2017

Compliance of pharmacotherapy with GOLD-guidelines: a longitudinal study in patients with COPD
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


The diagnosis of cystic fibrosis in adult COPD patients. A survey of 54 patients
Source: Eur Respir J 2001; 18: Suppl. 33, 215s
Year: 2001

Clinical response to elexacaftor/tezacaftor/ivacaftor for cystic fibrosis patients in a compassionate use setting
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020


An observational study assessing the practice of long-term azithromycin prescription in bronchiectasis
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012

Effects of eight week combined home and outpatient pulmonary rehabilitation in patients with COPD: A Korean multicenter observational study
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017

Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy.
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


STARMAP: an observational study to assess disease-relevant outcomes using home-monitoring devices in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Physiotherapy adherence and perception in patients with cystic fibrosis: A descriptive study
Source: International Congress 2015 – Physiotherapy assessment and techniques in pulmonary and non-pulmonary conditions
Year: 2015


Home oxygen saturation monitoring and quality of life in patients with idiopathic pulmonary fibrosis: A prospective multicenter trial
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Compliance with treatment in UK children with cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001